ArticleJournal of veterinary internal medicine2018

A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease.

Daniel K Newhard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.